Marijuana extract reduces seizures in patients with Lennox-Gastaut Syndrome in clinical trial.

GW Pharmaceuticals, the maker of a marijuana-based drug used to help children with rare forms of epilepsy, announced successful clinical trials of the drug Epidiolex in the treatment of Lennox-Gastaut Syndrome (LGS).

Epidiolex is made from pharmaceutical-grade cannabidiol (CBD) oil, a nonpsychoactive compound extracted from the cannabis plant.

In this randomized, double-blind, placebo-controlled Phase 3 clinical trial of the drug, Epidiolex was found to successfully reduce seizures in patients with LGS, a rare and severe form of epilepsy that develops in childhood.

Click here to read the complete article

Emily Gray Brosious ~ ~

Recent News Articles

Monday June 17

Hemp, and hope, sprouts in Minnesota fields - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

It’s springtime for hemp — the dawn of a new age for Minnesota agriculture.

862 hits

Monday June 17

Scottish mum praises effects of banned cannabis oil on son’s epilepsy - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

Karen can only get the cannabis oil by travelling abroad – and to bring it…

498 hits

Monday June 17

As Medical Cannabis Moves Mainstream, are Rheumatologists Prepared? - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

As more and more patients are using the drug, either legally or illegally depending on…

537 hits

Monday June 17

How to Eat, Drink, and Appreciate Cannabis at Restaurants - Cannabis News

in Culture & Arts

by Bruce Kennedy - Editor in Chief

From infusions to strain-specific cooking, veteran chefs are forging new identities while up-and-comers are making…

525 hits

Tuesday June 18

United States of Weed - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

Curious about the status of cannabis? Here’s a map of where marijuana legalization stands across…

215 hits